Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III, Seamless, Multicenter, Randomized, Open-Label, Positive-Comparator Controlled Clinical Trial to Evaluate the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency

NCT07126288 is registered in ClinicalTrials.gov with Shenzhen Kexing Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07126288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III, Seamless, Multicenter, Randomized, Open-Label, Positive-Comparator Controlled Clinical Trial to Evaluate the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
Lead sponsor
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
December 23, 2028
Enrollment
268 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone, growth hormone deficiency (ghd), growth hormone deficiency in children